From heart failure to health: Pump shown to restore organ to fitness

April 10, 2017, Newcastle University
heart
Human heart. Credit: copyright American Heart Association

As we face a shortage of donated hearts for transplant, the study authors are calling for the devices to be considered as a tool which can allow patients to restore their health.

The research examined the effect of mechanical heart pumps, known as left (LVAD).

The devices are used to support with severe while they wait for a .

Surgeons implant the battery operated, mechanical pump which helps the main pumping chamber of the heart- the left ventricle - - to push blood around the body. Fitted at the six specialist NHS centres across the UK, LVADs are used for patients who have reached the end stage of heart failure.

Publishing today in the Journal of American College of Cardiology, the team report that LVAD combined with medication can fully restore heart function in patients.

Dr Djordje Jakovljevic, Senior Research Fellow in Cardiovascular Ageing and Heart Failure within the Institute of Cellular Medicine at Newcastle University, is lead author on the paper.

He said: "We talk about these devices as a bridge-to-transplant, something which can keep a patient alive until a heart is available for transplantation.

"However, we knew that sometimes patients recover to such an extent that they no longer need a heart transplant.

"For the first time, what we have shown is that heart function is restored in some patients - to the extent that they are just like someone healthy who has never had heart disease. In effect, these devices can be a bridge to full recovery in some patients."

Tool to recovery

In the clinical trial, 58 men with heart failure were tested for their heart fitness levels. Of the men, 16 were fitted with an LVAD and then had it removed due to the extent of their recovery. Furthermore 18 still had an LVAD and 24 patients were waiting for a heart transplant. On average, a patient had a device fitted for 396 days before it was removed, though it varied from 22 days to 638 days.

The participants were compared with 97 healthy men who had no known . All were tested on a treadmill with a face mask to monitor their oxygen utilisation and heart pumping capability.

In the publication the authors report that 38% of people who recover enough to allow the device to be removed demonstrated a heart function which was equivalent to that of a healthy individual of the same age.

Dr Jakovljevic explains: "We can consider these pumps as a tool which can lead to a patient recovering, rather than as a device which keeps people alive until a heart transplant is available.

"Our ongoing and future research is aiming to identify the markers of early heart recovery while patients are fitted with a device. These markers will inform clinical care teams to make right decisions about which patient respond well to device and when to consider potential removal or disconnection of the device while ensuring heart failure will not occur again in the future."

Although heart transplantation offers a second chance of life for patients with advanced heart failure, a shortage of donor hearts has opened doors for developments and use of mechanical devices.

Dr Guy MacGowan, Consultant Cardiologist within the Newcastle upon Tyne Hospitals NHS Foundation Trust, and Honorary Clinical Reader in Heart Failure at Newcastle University, is co-author of the paper.

He said: "It is very difficult to get a heart transplant, especially in the UK, so any alternative treatment is important and recovery of heart function especially so. The UK has a long way to go in comparison with the number of heart transplants in other developed countries.

"Within Newcastle upon Tyne Hospitals NHS Foundation Trust, we are pioneering a new strategy to use the LVAD to enhance chances of recovery, monitor for signs of recovery, and then use a minimally invasive procedure to disconnect the device."

Consultant Cardiac Surgeon within the Newcastle upon Tyne Hospitals NHS Foundation Trust and co-author, Professor Stephan Schueler, added: "In most cases the device reverses the symptoms of heart failure so that patients feel less short of breath and with less fatigue. In a smaller proportion of patients there is actually an improvement in so that the pump can be disconnected or explanted."

The average price of a LVAD is approximately £80,000 and the transplant operation costs around £69,000.

The team involved researchers at Newcastle, Cambridge, Leeds, London and Louisville (USA) who are currently studying how to identify patients who will respond best to being fitted with an LVAD by identifying markers of early recovery.

Explore further: Drug therapy, LVAD helps severe heart failure patients recover function

More information: Left Ventricular Assist Device as a Bridge to Recovery for Patients With Advanced Heart Failure, Journal of the American College of Cardiology, 2017. DOI: 10.1016/j.jacc.2017.02.018, www.sciencedirect.com/science/ … ii/S0735109717306204

Related Stories

Drug therapy, LVAD helps severe heart failure patients recover function

November 13, 2016
More than a third of advanced heart failure patients treated with a combination of an artificial heart assist device, called a left ventricular assist device, or LVAD, and intensive drug therapy have recovered their heart ...

Treatment options for heart failure

February 16, 2017
Ask any doctor what can be done to maintain a healthy heart and the answer will most likely be to eat healthy and exercise regularly. But what happens when someone's heart is not healthy and does not pump blood properly? ...

Biomarker could identify patients with potential for recovery from advanced heart failure

January 17, 2017
Investigators at the University of Utah have identified distinct differences in the hearts of advanced heart failure patients who have defied the odds and showed signs of recovery from the disease. Published online in the ...

Stem cell patch shows early promise in treating heart failure

April 5, 2017
Patching a damaged heart with a patient's own muscle stem cells improves symptoms of heart failure, according to a Phase I clinical trial reported in Journal of the American Heart Association, the Open Access Journal of the ...

Successful implant of next-generation heart device marks Canadian first

November 10, 2014
A surgical team at the Peter Munk Cardiac Centre led by internationally-acclaimed cardiovascular surgeon, Dr. Vivek Rao, has successfully implanted a novel mechanical device, the HeartMate IIITM, into a patient with advanced ...

New patient guidelines for heart devices

April 17, 2011
A series of new guidelines for cardiac specialists has been developed to determine when heart failure patients should receive a mechanical heart-pumping device.

Recommended for you

New model suggests cuffless, non-invasive blood pressure monitoring possible using pulse waves

October 16, 2018
A large team of researchers from several institutions in China and the U.S. has developed a model that suggests it should be possible to create a cuffless, non-invasive blood pressure monitor based on measuring pulse waves. ...

Why heart contractions are weaker in those with hypertrophic cardiomyopathy

October 16, 2018
When a young athlete suddenly dies of a heart attack, chances are high that they suffer from familial hypertrophic cardiomyopathy (HCM). Itis the most common genetic heart disease in the US and affects an estimated 1 in 500 ...

Novel genetic study sheds new light on risk of heart attack

October 12, 2018
Loss of a protein that regulates mitochondrial function can greatly increase the risk of myocardial infarction (heart attack), Vanderbilt scientists reported Oct. 3 in the journal eLife.

Researchers say ritual for orthodox Jewish men may offer heart benefits

October 11, 2018
A pilot study led by researchers at the University of Cincinnati (UC) College of Medicine suggests Jewish men who practice wearing tefillin, which involves the tight wrapping of an arm with leather banding as part of daily ...

Markers of dairy fat consumption linked to lower risk of type two diabetes

October 10, 2018
Higher levels of biomarkers of dairy fat consumption are associated with a lower risk of developing type 2 diabetes, according to new research published today in PLOS Medicine. The study, in more than 60,000 adults, was undertaken ...

Seed oils are best for LDL cholesterol

October 9, 2018
If you want to lower your low-density lipoprotein cholesterol, called LDL or, colloquially, "bad cholesterol," the research is clear about one thing: You should exchange saturated fats with unsaturated fat. If you want to ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

TheNorwalkAvenger
not rated yet Apr 10, 2017
This is amazing news, provided some eager resident intern doesn't come along and cut them.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.